STOCK TITAN

Tenax Therapeutics, Inc. (TENX) Net Income by Year

TENX

Tenax Therapeutics, Inc. reported a net loss of $52.6M in fiscal year 2025. This represents a decrease of 198.9% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2025, and the quarters Tenax Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$52.6M
YoY -198.9%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TENX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1510-KFY1410-KFY1310-KFY1210-K
Net Income-$52.6M-198.9%-$17.6M-128.6%-$7.7M-169.7%$11.0MN/A-$9.9M-17.4%-$8.4M+40.7%-$14.1M-60.0%-$8.8M+79.9%-$43.9MN/A-$14.1M+27.9%-$19.5M-107.5%-$9.4M+40.1%-$15.7M

TENX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$17.8M-64.1%-$15.7M-51.0%N/A-$15.8M-299.0%-$10.8M-203.4%-$10.4M-174.0%N/A-$4.0M-300.9%-$3.6M-223.1%-$3.8M-170.1%N/A$2.0M-32.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Tenax Therapeutics, Inc. financials

Frequently Asked Questions

What was Tenax Therapeutics, Inc.'s net income in fiscal year 2025?

Tenax Therapeutics, Inc. reported a net loss of $52.6M in fiscal year 2025.

How fast is Tenax Therapeutics, Inc.'s net income growing?

Tenax Therapeutics, Inc. (TENX) net income fell by 198.9% year over year, from -$17.6M to -$52.6M in fiscal year 2025.

How has Tenax Therapeutics, Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, Tenax Therapeutics, Inc. (TENX) net income went from -$15.7M in fiscal year 2012 to -$52.6M in fiscal year 2025.

Tenax Therapeutics, Inc. (TENX) reported -$17.8M in net income in Q2 2026. This represents a decrease of 64.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Tenax Therapeutics, Inc. (TENX) reported on that line in every period on record.